|
Market Closed -
Nasdaq
00:00:00 29/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 16.00 USD | +0.13% |
|
+0.63% | +101.01% |
| 10-27 | Alert from law firm tagged to Personalis withdrawn | RE |
| 10-21 | Personalis, Inc. Announces NeXT Personal Ultrasensitive Circulating Tumor DNA Test Presentations at ESMO Congress 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Medical & Diagnostic Laboratories
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.71B | - | ||||
| 117B | |||||
| 97.42B | |||||
| 59.22B | - | ||||
| 29.03B | |||||
| 26.86B |
- Stock Market
- Stocks
- PSNL Stock
- Charts Personalis, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
